» Articles » PMID: 28808156

Identification of Staphylococcus Aureus Factors Required for Pathogenicity and Growth in Human Blood

Overview
Journal Infect Immun
Date 2017 Aug 16
PMID 28808156
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

is a human commensal but also has devastating potential as an opportunistic pathogen. bacteremia is often associated with an adverse outcome. To identify potential targets for novel control approaches, we have identified components that are required for growth in human blood. An ordered transposon mutant library was screened, and 9 genes involved specifically in hemolysis or growth on human blood agar were identified by comparing the mutants to the parental strain. Three genes (, , and ) were subsequently found to be required for pathogenesis in the zebrafish embryo infection model. The growth defect was specific to the red blood cell component of human blood, showing no difference from the parental strain in growth in human serum, human plasma, or sheep or horse blood. PabA is required in the tetrahydrofolate (THF) biosynthesis pathway. The growth defect was found to be due to a combination of loss of THF-dependent dTMP production by the ThyA enzyme and increased demand for pyrimidines in human blood. Our work highlights and the pyrimidine salvage pathway as potential targets for novel therapeutics and suggests a previously undefined role for a human blood factor in the activity of sulfonamide antibiotics.

Citing Articles

Low leucine levels in the blood enhance the pathogenicity of neonatal meningitis-causing Escherichia coli.

Sun H, Li X, Yang X, Qin J, Liu Y, Zheng Y Nat Commun. 2025; 16(1):2466.

PMID: 40075077 PMC: 11904087. DOI: 10.1038/s41467-025-57850-2.


Clinical and in vitro models identify distinct adaptations enhancing Staphylococcus aureus pathogenesis in human macrophages.

Long D, Holmes E, Lo H, Penewit K, Almazan J, Hodgson T PLoS Pathog. 2024; 20(7):e1012394.

PMID: 38991026 PMC: 11265673. DOI: 10.1371/journal.ppat.1012394.


Determinants of bacterial survival and proliferation in blood.

Le-Bury P, Echenique-Rivera H, Pizarro-Cerda J, Dussurget O FEMS Microbiol Rev. 2024; 48(3).

PMID: 38734892 PMC: 11163986. DOI: 10.1093/femsre/fuae013.


Substrate Analogues Entering the Lipoic Acid Salvage Pathway via Lipoate-Protein Ligase 2 Interfere with Virulence.

Scattolini A, Grammatoglou K, Nikitjuka A, Jirgensons A, Mansilla M, Windshugel B ACS Infect Dis. 2024; 10(6):2172-2182.

PMID: 38724014 PMC: 11184557. DOI: 10.1021/acsinfecdis.4c00148.


A journey into the regulatory secrets of the purine nucleotide biosynthesis.

Ayoub N, Gedeon A, Munier-Lehmann H Front Pharmacol. 2024; 15:1329011.

PMID: 38444943 PMC: 10912719. DOI: 10.3389/fphar.2024.1329011.


References
1.
Wright J, Nair S . The lipoprotein components of the Isd and Hts transport systems are dispensable for acquisition of heme by Staphylococcus aureus. FEMS Microbiol Lett. 2012; 329(2):177-85. DOI: 10.1111/j.1574-6968.2012.02519.x. View

2.
Powers M, Bubeck Wardenburg J . Igniting the fire: Staphylococcus aureus virulence factors in the pathogenesis of sepsis. PLoS Pathog. 2014; 10(2):e1003871. PMC: 3923759. DOI: 10.1371/journal.ppat.1003871. View

3.
Prajsnar T, Cunliffe V, Foster S, Renshaw S . A novel vertebrate model of Staphylococcus aureus infection reveals phagocyte-dependent resistance of zebrafish to non-host specialized pathogens. Cell Microbiol. 2008; 10(11):2312-25. DOI: 10.1111/j.1462-5822.2008.01213.x. View

4.
Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

5.
Bae T, Banger A, Wallace A, Glass E, Aslund F, Schneewind O . Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing. Proc Natl Acad Sci U S A. 2004; 101(33):12312-7. PMC: 514475. DOI: 10.1073/pnas.0404728101. View